Literature DB >> 15223240

Inflammatory response during bacterial meningitis is unchanged in Fas- and Fas ligand-deficient mice.

Robert Paul1, Barbara Angele, Bernd Sporer, Hans-Walter Pfister, Uwe Koedel.   

Abstract

Fas (CD95) and Fas ligand (FasL, CD95L) have been implicated to be involved in the acute inflammatory response by attracting neutrophils and regulating their survival. Increased levels of soluble Fas and FasL are found in cerebrospinal fluid (CSF) samples of patients with bacterial meningitis but not in controls. Functional FasL (gld)- or Fas (lpr)-deficient mice were used to assess their role in the pathophysiology of pneumococcal meningitis. Induction of meningitis in wild-type (WT) mice caused an increase in CSF white blood cell (WBC) count, intracranial pressure (ICP), and vessel permeability, paralleled by a worse clinical status at 24 h. The inflammatory response was accompanied by elevated levels of IL-1beta, MMP-2, and MMP-9 in the brain. Neither gld- nor lpr-mice showed significant differences in the above-mentioned pneumococci-induced pathophysiological alterations. These results indicate that Fas and FasL are not essential in the regulation of the acute inflammatory response during pneumococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223240     DOI: 10.1016/j.jneuroim.2004.04.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Caspase activation in fetal rat brain following experimental intrauterine inflammation.

Authors:  Aditi Sharangpani; Asako Takanohashi; Michael J Bell
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

3.  Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.

Authors:  Jairam R Lingappa; Logan Dumitrescu; Shanta M Zimmer; Ruth Lynfield; Janet M McNicholl; Nancy E Messonnier; Cynthia G Whitney; Dana C Crawford
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

4.  Modulation of hippocampal neuroplasticity by Fas/CD95 regulatory protein 2 (Faim2) in the course of bacterial meningitis.

Authors:  Simone C Tauber; Kristian Harms; Björn Falkenburger; Joachim Weis; Bernd Sellhaus; Roland Nau; Jörg B Schulz; Arno Reich
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

5.  Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

Authors:  U R Goonetilleke; S A Ward; S B Gordon
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-27

6.  Interactions between blood-borne Streptococcus pneumoniae and the blood-brain barrier preceding meningitis.

Authors:  Federico Iovino; Carlos J Orihuela; Henk E Moorlag; Grietje Molema; Jetta J E Bijlsma
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

7.  Apoptosis in cerebrospinal fluid as outcome predictors in severe traumatic brain injury: An observational study.

Authors:  Wenqing Jiang; Peng Jin; Wenfeng Wei; Wei Jiang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.